Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

11 trials with published results (26%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

4.7%

2 terminated out of 43 trials

Success Rate

93.1%

+6.5% vs benchmark

Late-Stage Pipeline

28%

12 trials in Phase 3/4

Results Transparency

41%

11 of 27 completed with results

Key Signals

11 with results93% success

Data Visualizations

Phase Distribution

39Total
Not Applicable (22)
Early P 1 (1)
P 1 (1)
P 2 (3)
P 3 (5)
P 4 (7)

Trial Status

Completed27
Active Not Recruiting4
Recruiting4
Unknown3
Not Yet Recruiting2
Terminated2

Trial Success Rate

93.1%

Benchmark: 86.6%

Based on 27 completed trials

Clinical Trials (43)

Showing 20 of 20 trials
NCT06118268Not ApplicableRecruiting

iTBS to Enhance Social Cognition in People With Psychosis

NCT07006935Not ApplicableRecruiting

REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)

NCT06041646Phase 4Completed

Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder

NCT04268303Phase 3Completed

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia

NCT05658510Phase 3Completed

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

NCT07116694Phase 2Completed

Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder

NCT05877716Not ApplicableActive Not Recruiting

EPI-MINN: Targeting Cognition and Motivation - National

NCT04004416Phase 4Completed

Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis

NCT04113993Phase 4Recruiting

Bazedoxifene -Treatment for Women With Schizophrenia

NCT05416658Not ApplicableNot Yet Recruiting

Shared Decision Making for Antipsychotic Medications

NCT03919760Not ApplicableCompleted

Early Psychosis Intervention - Spreading Evidence-based Treatment

NCT04298450Not ApplicableCompleted

ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention

NCT06251908Not ApplicableActive Not RecruitingPrimary

REWRITALIZE Your Recovery - Evaluation of a Creative Writing Group Intervention

NCT05974527Phase 4Withdrawn

Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department

NCT04497857Not ApplicableCompleted

Academic-Community EPINET (AC-EPINET)

NCT05538832Early Phase 1Completed

Remote State Representation in Early Psychosis

NCT06002958Not ApplicableTerminated

Horyzons: Implementation and Integration in Clinical Practice

NCT05756855Not ApplicableActive Not Recruiting

Young Adults With Violent Behavior During Early Psychosis (Aim 2)

NCT05109065Completed

Peripheral Immune System in Individuals With Schizophrenia

NCT06278246Active Not Recruiting

Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography

Scroll to load more

Research Network

Activity Timeline